According to the latest data from the Hong Kong Stock Exchange, on April 17, JPMorgan reduced its holding in Pharmaron (03759) by 605,052 shares. The transaction was executed at a price of HK$21.3947 per share, amounting to a total value of approximately HK$12.9449 million. Following this reduction, JPMorgan's updated shareholding stands at around 21.0476 million shares, representing a stake of 5.84%.